Idience Co., Ltd.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Food Effect Study of IDX-1197 in Healthy Subjects (NCT05202912) | Idience Co., Ltd. | 2022-01-16 |
| Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer (NCT04725994) | Idience Co., Ltd. | 2021-06-28 |
| Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS) (NCT04174716) | Idience Co., Ltd. | 2019-11-06 |
| Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors (NCT03317743) | Idience Co., Ltd. | 2017-08-29 |
Track Idience Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.